Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 345

1.

Neuropathy progression in Charcot-Marie-Tooth disease type 1A.

Shy ME, Chen L, Swan ER, Taube R, Krajewski KM, Herrmann D, Lewis RA, McDermott MP.

Neurology. 2008 Jan 29;70(5):378-83. doi: 10.1212/01.wnl.0000297553.36441.ce.

PMID:
18227419
2.

Reliability and validity of the CMT neuropathy score as a measure of disability.

Shy ME, Blake J, Krajewski K, Fuerst DR, Laura M, Hahn AF, Li J, Lewis RA, Reilly M.

Neurology. 2005 Apr 12;64(7):1209-14.

PMID:
15824348
3.

Utility of Charcot-Marie-Tooth Neuropathy Score in children with type 1A disease.

Haberlová J, Seeman P.

Pediatr Neurol. 2010 Dec;43(6):407-10. doi: 10.1016/j.pediatrneurol.2010.06.004.

PMID:
21093731
4.

Diabetes mellitus exacerbates motor and sensory impairment in CMT1A.

Sheth S, Francies K, Siskind CE, Feely SM, Lewis RA, Shy ME.

J Peripher Nerv Syst. 2008 Dec;13(4):299-304. doi: 10.1111/j.1529-8027.2008.00196.x.

PMID:
19192070
5.

Mechanisms of neuropathic pain in patients with Charcot-Marie-Tooth 1 A: a laser-evoked potential study.

Pazzaglia C, Vollono C, Ferraro D, Virdis D, Lupi V, Le Pera D, Tonali P, Padua L, Valeriani M.

Pain. 2010 May;149(2):379-85. doi: 10.1016/j.pain.2010.03.001. Epub 2010 Mar 23.

PMID:
20334975
6.

Charcot-Marie-Tooth disease type 1A duplication: spectrum of clinical and magnetic resonance imaging features in leg and foot muscles.

Gallardo E, García A, Combarros O, Berciano J.

Brain. 2006 Feb;129(Pt 2):426-37. Epub 2005 Nov 29.

PMID:
16317020
7.

In vivo confocal microscopy of Meissner corpuscles as a novel sensory measure in CMT1A.

Almodovar JL, Ferguson M, McDermott MP, Lewis RA, Shy ME, Herrmann DN.

J Peripher Nerv Syst. 2011 Sep;16(3):169-74. doi: 10.1111/j.1529-8027.2011.00342.x.

PMID:
22003930
8.

Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A.

Krajewski KM, Lewis RA, Fuerst DR, Turansky C, Hinderer SR, Garbern J, Kamholz J, Shy ME.

Brain. 2000 Jul;123 ( Pt 7):1516-27.

PMID:
10869062
9.

Selected items from the Charcot-Marie-Tooth (CMT) Neuropathy Score and secondary clinical outcome measures serve as sensitive clinical markers of disease severity in CMT1A patients.

Mannil M, Solari A, Leha A, Pelayo-Negro AL, Berciano J, Schlotter-Weigel B, Walter MC, Rautenstrauss B, Schnizer TJ, Schenone A, Seeman P, Kadian C, Schreiber O, Angarita NG, Fabrizi GM, Gemignani F, Padua L, Santoro L, Quattrone A, Vita G, Calabrese D; CMT-TRIAAL/CMT-TRAUK Group, Young P, Laurà M, Haberlová J, Mazanec R, Paulus W, Beissbarth T, Shy ME, Reilly MM, Pareyson D, Sereda MW.

Neuromuscul Disord. 2014 Nov;24(11):1003-17. doi: 10.1016/j.nmd.2014.06.431. Epub 2014 Jun 19.

PMID:
25085517
10.

Reliability of the CMT neuropathy score (second version) in Charcot-Marie-Tooth disease.

Murphy SM, Herrmann DN, McDermott MP, Scherer SS, Shy ME, Reilly MM, Pareyson D.

J Peripher Nerv Syst. 2011 Sep;16(3):191-8. doi: 10.1111/j.1529-8027.2011.00350.x.

11.

Electrophysiological characterization of Charcot-Marie-Tooth disease type 1A in Taiwan.

Huang LW, Lin KP, Chang MH, Liao YC, Liao KK, Soong BW, Lee YC.

J Chin Med Assoc. 2012 May;75(5):197-202. doi: 10.1016/j.jcma.2012.03.005. Epub 2012 Apr 29.

12.

The natural history of Charcot-Marie-Tooth type 1A in adults: a 5-year follow-up study.

Verhamme C, van Schaik IN, Koelman JH, de Haan RJ, de Visser M.

Brain. 2009 Dec;132(Pt 12):3252-62. doi: 10.1093/brain/awp251.

PMID:
19843647
13.
15.

NT-3 promotes nerve regeneration and sensory improvement in CMT1A mouse models and in patients.

Sahenk Z, Nagaraja HN, McCracken BS, King WM, Freimer ML, Cedarbaum JM, Mendell JR.

Neurology. 2005 Sep 13;65(5):681-9.

PMID:
16157899
16.

Neuromuscular hip dysplasia in Charcot-Marie-Tooth disease type 1A.

Bamford NS, White KK, Robinett SA, Otto RK, Gospe SM Jr.

Dev Med Child Neurol. 2009 May;51(5):408-11.

PMID:
19388151
17.

Disease course of Charcot-Marie-Tooth disease type 2: a 5-year follow-up study.

Teunissen LL, Notermans NC, Franssen H, Van Engelen BG, Baas F, Wokke JH.

Arch Neurol. 2003 Jun;60(6):823-8.

PMID:
12810486
18.

A Rasch Analysis of the Charcot-Marie-Tooth Neuropathy Score (CMTNS) in a Cohort of Charcot-Marie-Tooth Type 1A Patients.

Wang W, Guedj M, Bertrand V, Foucquier J, Jouve E, Commenges D, Proust-Lima C, Murphy NP, Blin O, Magy L, Cohen D, Attarian S.

PLoS One. 2017 Jan 17;12(1):e0169878. doi: 10.1371/journal.pone.0169878. eCollection 2017.

19.

Clinical and electrophysiologic features of HNPP patients with 17p11.2 deletion.

Hong YH, Kim M, Kim HJ, Sung JJ, Kim SH, Lee KW.

Acta Neurol Scand. 2003 Nov;108(5):352-8.

PMID:
14616306
20.

Clinical and electrophysiological features in Charcot-Marie-Tooth disease with mutations in the NEFL gene.

Miltenberger-Miltenyi G, Janecke AR, Wanschitz JV, Timmerman V, Windpassinger C, Auer-Grumbach M, Löscher WN.

Arch Neurol. 2007 Jul;64(7):966-70.

PMID:
17620486

Supplemental Content

Support Center